Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
cvi-lm001 (1 trial)
Hypercholesterolemia (Phase 2)
Hyperlipidemias (Phase 2)
Trials (1 total)
Trial APIs (1 total)